We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current JWCTF market cap is 118.09M. The company's latest EPS is CNY -1.8535 and P/E is -0.15.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 5.48M | 1.32M | 37.24M | 145.7M | 173.86M |
| Operating Income | -203.52M | -468.46M | -771.16M | -696.32M | -751.6M |
| Net Income | -633.26M | -1.66B | -702.33M | -846.14M | -768M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 668.62M | 3.78B | 3.12B | 2.79B | 2.15B |
| Total Liabilities | 1.61B | 349.76M | 325.75M | 437.06M | 462.26M |
| Total Equity | -942.34M | 3.43B | 2.79B | 2.35B | 1.68B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -188.92M | -261.01M | -561.2M | -536.72M | -398.42M |
| Investing | -117.55M | -91.91M | -137.13M | -124.08M | 9.9M |
| Financing | 414.05M | 2.86B | -30.62M | 112.35M | 275k |
| Market Cap | 118.09M |
| Price to Earnings Ratio | -0.15 |
| Price to Sales Ratio | 0.67 |
| Price to Cash Ratio | 0.12 |
| Price to Book Ratio | 0.07 |
| Dividend Yield | - |
| Shares Outstanding | 414.36M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 100 |
| 52 Week Change | -12.31% |
| 52 Week High | 0.41 |
| 52 Week Low | 0.215 |
| Spread (Intraday) | 0.05 (16.95%) |
| Company Name | JW Cayman Therapeutics Company Ltd (PK) |
| Address |
the offices of maples corporate services limited grand cayman KY1-1104 |
| Website | https://www.jwtherapeutics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
